Work

A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days

Year: 1999

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s002800050911

Authors: Mark D. DeMario, Mark J. Ratain, Nicholas J. Vogelzang, Sridhar Mani, Everett E. Vokes, Gini F. Fleming, Kimberly Melton, Sheryl Johnson, Steven Benner, David Lebwohl

Institutions: University of Chicago, University of Chicago Medical Center, Bristol-Myers Squibb (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2080112732

FWCI: 0.275

Cites: 7

Cited by: 16

Related to: 10